Tokai Pharma (TKAI) Will Discontinue Enrollment in ARMOR2 Expansion Trial
Tweet Send to a Friend
Tokai Pharma (NASDAQ: TKAI) disclosed the following on Monday:Item 7.01. Regulation FD DisclosureTokai Pharmaceuticals, Inc. (“Tokai”) has determined to discontinue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
